The new facility, with a capacity of 3,120 MT per month, will focus on producing advanced cellulose and starch-based excipients, along with other high-value ingredients vital for the pharmaceutical, nutraceutical, and food industries. Located within an SEZ, the plant is designed to enhance exports, provide greater operational flexibility, and adhere to strict international standards.

The Dahej project is expected to strengthen Sigachi’s position in international supply chains and facilitate the company’s expansion into rapidly growing global markets.

The company stated that the expansion is a reflection of its commitment to building world-class manufacturing capabilities. The project aligns with India’s “Make in India” initiative, positioning the country as a significant global player in pharmaceutical manufacturing.

News source: Manufacturing Today